Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The advent of stem cell-derived retinal organoids has brought forth unprecedented opportunities for developmental and physiological studies, while presenting new therapeutic promise for retinal degenerative diseases. From a translational perspective, organoid systems provide exciting new prospects for drug discovery, offering the possibility to perform compound screening in a three-dimensional (3D) human tissue context that resembles the native histoarchitecture and to some extent recapitulates cellular interactions. However, inherent variability issues and a general lack of robust quantitative technologies for analyzing organoids on a large scale pose severe limitations for their use in translational applications. To address this need, we have developed a screening platform that enables accurate quantification of fluorescent reporters in complex human iPSC-derived retinal organoids. This platform incorporates a fluorescence microplate reader that allows xyz-dimensional detection and fine-tuned wavelength selection. We have established optimal parameters for fluorescent reporter signal detection, devised methods to compensate for organoid size variability, evaluated performance and sensitivity parameters, and validated this technology for functional applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 2×
“…compound identification, but when taken to clinical trials 90% of these compounds fail to progress through phase I, resulting in billions of dollars in economic losses and delays in the development of much-needed therapeutic agents (Hynds and Giangreco, 2013; Paul et al., 2010; Ranga et al., 2014).”
BackgroundOrganoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · cited 6×
“…cellbased models and technologies, and for good reason, since these systems have opened up numerous opportunities for basic research and clinical applications (Canto-Soler et al., 2016; Fatehullah et al., 2016; Hynds and Giangreco, 2013; Wright et al., 2014; Xinaris et al., 2015; Yin et al., 2016).”
BackgroundInfluentialGeneration of three-dimensional retinal tissue with functional photoreceptors from human iPSCs
Zhong, X., Gutierrez, C., Xue, T., Hampton, C., Vergara, M. N., Cao, L.-H., Peters, A., Park, T. S., Zambidis, E. T., Meyer, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5047 · Cited by 970 · cited 9×
“…at various differentiation stages were fixed in 4% paraformaldehyde for 10 min and labeled using rabbit antiOtx2 antibody (Millipore, AB9566; Zhong et al., 2014) or goat anti-Brn3b (Pou4f2) antibody (Santa Cruz Biotechnologies, SC-6026x), followed by incubation with goat anti-rabbit Alexa…”
BackgroundMethodResultInfluentialSelf-citationOxidative damage-induced inflammation initiates age-related macular degeneration
Hollyfield, J. G., Bonilha, V. L., Rayborn, M. E., Yang, X., Shadrach, K. G., Lu, L., Ufret, R. L., Salomon, R. G., & Perez, V. L. (2008) · Nature Medicine · doi:10.1038/nm1709 · Cited by 710 · cited 1×
“…is at the basis of the pathophysiology of many chronic diseases, including those affecting the retina (Athanasiou et al., 2013; Cano et al., 2010; Hollyfield et al., 2008; Jarrett and Boulton, 2012; Kowluru and Chan, 2007; Masuda et al., 2017; Nita and Grzybowski, 2016; Nishimura et al., 2017;…”
BackgroundDrug discovery through stem cell-based organoid models
Ranga, A., Gjorevski, N., & Lutolf, M. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.006 · Cited by 195 · cited 4×
“In this scenario, human stem cell-derived organoids have the potential to bridge the gap between primary compound screening, costly animal studies, and human trials, as they provide a more physiologically relevant, human-based context, while allowing the necessary flexibility and level of control of an in vitro system…”
BackgroundInfluential
Cited by
Human organoids in basic research and clinical applications
Tang, X.-Y., Wu, S., Wang, D., Chu, C., Hong, Y., Tao, M., Hu, H., Xu, M., Guo, X., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01024-9 · Cited by 484
Solving neurodegeneration: common mechanisms and strategies for new treatments
Wareham, L. K., Liddelow, S. A., Temple, S., Benowitz, L. I., Di Polo, A., Wellington, C., Goldberg, J. L., He, Z., Duan, X., Bu, G., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00524-0 · Cited by 324
Self-citationPluripotent stem cell-derived retinal organoids for disease modeling and development of therapies
Kruczek, K., & Swaroop, A. (2020) · Stem Cells · doi:10.1002/stem.3239 · Cited by 148
“now being adapted to search for small molecule therapeutic compounds using high-throughput screening strategies.(53,54)”
BackgroundHuman retinal model systems: Strengths, weaknesses, and future directions
Eldred, K. C., & Reh, T. A. (2021) · Developmental Biology · doi:10.1016/j.ydbio.2021.09.001 · Cited by 41
Metadata
- Authors
- Vergara, M. N., Flores-Bellver, M., Aparicio-Domingo, S., McNally, M., Wahlin, K. J., Saxena, M. T., Mumm, J. S., & Canto-Soler, M. V.
- Venue
- Development
- Publisher
- The Company of Biologists
- Published
- 2017-10-15
- Volume
- 144
- Issue
- 20
- Pages
- 3698-3705
- ISSN
- 0950-1991 (ISSN-L)
- 1477-9129
- OpenAlex
- W2751345613
- Cited by
- 77
- References
- 5
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids. https://app.cochat.ai/papers/10.1242/dev.146290
- The paper
- Vergara, M. N., Flores-Bellver, M., Aparicio-Domingo, S., McNally, M., Wahlin, K. J., Saxena, M. T., Mumm, J. S., & Canto-Soler, M. V. (2017). Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids. Development. https://doi.org/10.1242/dev.146290
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.